Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 263

1.

Notch2 regulates matrix metallopeptidase 9 via PI3K/AKT signaling in human gastric carcinoma cell MKN-45.

Guo LY, Li YM, Qiao L, Liu T, Du YY, Zhang JQ, He WT, Zhao YX, He DQ.

World J Gastroenterol. 2012 Dec 28;18(48):7262-70. doi: 10.3748/wjg.v18.i48.7262.

2.

C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.

Wang L, Yin J, Wang X, Shao M, Duan F, Wu W, Peng P, Jin J, Tang Y, Ruan Y, Sun Y, Gu J.

Gastroenterology. 2016 May;150(5):1183-1195.e16. doi: 10.1053/j.gastro.2016.01.034. Epub 2016 Feb 6.

PMID:
26855187
3.

RNA interference of PARG could inhibit the metastatic potency of colon carcinoma cells via PI3-kinase/Akt pathway.

Li Q, Li M, Wang YL, Fauzee NJ, Yang Y, Pan J, Yang L, Lazar A.

Cell Physiol Biochem. 2012;29(3-4):361-72. doi: 10.1159/000338491. Epub 2012 Apr 3. Erratum in: Cell Physiol Biochem. 2014;33(1):247-8.

4.

RNAi knockdown of PIK3CA preferentially inhibits invasion of mutant PIK3CA cells.

Zhou XK, Tang SS, Yi G, Hou M, Chen JH, Yang B, Liu JF, He ZM.

World J Gastroenterol. 2011 Aug 28;17(32):3700-8. doi: 10.3748/wjg.v17.i32.3700.

5.

BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.

Kang MH, Kim JS, Seo JE, Oh SC, Yoo YA.

Exp Cell Res. 2010 Jan 1;316(1):24-37. doi: 10.1016/j.yexcr.2009.10.010. Epub 2009 Oct 14.

PMID:
19835871
6.

Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells.

Miao F, Zhang X, Cao Y, Wang Y, Zhang X.

BMC Cancer. 2017 Dec 11;17(1):838. doi: 10.1186/s12885-017-3843-y.

7.

Expression of PI3K/AKT pathway in gastric cancer and its blockade suppresses tumor growth and metastasis.

Ye B, Jiang LL, Xu HT, Zhou DW, Li ZS.

Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):627-36.

PMID:
23058013
8.

Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.

Xu Z, Zhang Y, Jiang J, Yang Y, Shi R, Hao B, Zhang Z, Huang Z, Kim JW, Zhang G.

BMC Cancer. 2010 Apr 27;10:161. doi: 10.1186/1471-2407-10-161.

9.

LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells.

Shin JY, Kim JO, Lee SK, Chae HS, Kang JH.

BMC Cancer. 2010 Aug 13;10:425. doi: 10.1186/1471-2407-10-425.

10.

Upregulation of microRNA-31 targeting integrin α5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells.

Zhang XB, Song L, Wen HJ, Bai XX, Li ZJ, Ma LJ.

Tumour Biol. 2016 Jun;37(6):8317-25. doi: 10.1007/s13277-015-4511-y. Epub 2016 Jan 4.

PMID:
26729197
11.

Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.

Cheng YJ, Zhu ZX, Zhou JS, Hu ZQ, Zhang JP, Cai QP, Wang LH.

World J Gastroenterol. 2015 Feb 28;21(8):2323-35. doi: 10.3748/wjg.v21.i8.2323.

12.

CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.

Zang M, Zhang B, Zhang Y, Li J, Su L, Zhu Z, Gu Q, Liu B, Yan M.

PLoS One. 2014 Nov 14;9(11):e112908. doi: 10.1371/journal.pone.0112908. eCollection 2014.

13.

Downregulation of c-Met expression does not enhance the sensitivity of gastric cancer cell line MKN-45 to gefitinib.

Ma JA, Hu C, Li W, Ren J, Zou F, Zhou D, Zou W, Wei Y, Zhou Y.

Mol Med Rep. 2015 Mar;11(3):2269-75. doi: 10.3892/mmr.2014.2948. Epub 2014 Nov 13.

PMID:
25395073
14.

Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.

Hu C, Huang L, Gest C, Xi X, Janin A, Soria C, Li H, Lu H.

J Hematol Oncol. 2012 Jul 11;5:16. doi: 10.1186/1756-8722-5-16.

15.

Platelet-type 12-lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/Akt/NF-κB.

Dilly AK, Ekambaram P, Guo Y, Cai Y, Tucker SC, Fridman R, Kandouz M, Honn KV.

Int J Cancer. 2013 Oct 15;133(8):1784-91. doi: 10.1002/ijc.28165. Epub 2013 Jul 13.

16.

The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.

Huang TT, Ping YH, Wang AM, Ke CC, Fang WL, Huang KH, Lee HC, Chi CW, Yeh TS.

Oncotarget. 2015 Jul 20;6(20):18012-26.

17.

RNA interference-mediated knockdown of RhoGDI2 induces the migration and invasion of human lung cancer A549 cells via activating the PI3K/Akt pathway.

Niu H, Wu B, Peng Y, Jiang H, Zhang Y, Wang J, Zhang Y, He P.

Tumour Biol. 2015 Jan;36(1):409-19. doi: 10.1007/s13277-014-2671-9. Epub 2014 Sep 30. Erratum in: Tumour Biol. 2015 Jan;36(1):459.

PMID:
25266803
18.

CHRNA7 inhibits cell invasion and metastasis of LoVo human colorectal cancer cells through PI3K/Akt signaling.

Xiang T, Yu F, Fei R, Qian J, Chen W.

Oncol Rep. 2016 Feb;35(2):999-1005. doi: 10.3892/or.2015.4462. Epub 2015 Nov 27.

PMID:
26719016
19.
20.

RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway.

Sun HW, Tong SL, He J, Wang Q, Zou L, Ma SJ, Tan HY, Luo JF, Wu HX.

World J Gastroenterol. 2007 Jul 7;13(25):3517-22.

Supplemental Content

Support Center